XML 66 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation Expense

Our stock-based compensation expense for the three months ended March 31 was as follows:

 

     Three months ended
March 31,
 
     2014     2013  

Research and development expense

   $ 186,293      $ 343,711   

Selling, general and administrative expense

     334,813        342,871   
  

 

 

   

 

 

 

Total stock-based compensation

   $ 521,106      $ 686,582   
  

 

 

   

 

 

 

Effect on basic and diluted net loss per share

   $ (0.01   $ (0.02
  

 

 

   

 

 

 
Stock Option Activity

A summary of our stock option activity for the three months ended March 31, 2014 is as follows:

 

     Number of options     Weighted-average
exercise price ($) per share
 

Outstanding options at December 31, 2013

     428,258        19.97   

Granted

     —          —     

Exercised

     —          —     

Cancelled

     (46,407     35.81   
  

 

 

   

Outstanding options at March 31, 2014

     381,851        18.05   
  

 

 

 
Summary of Changes in Unvested Options

A summary of changes in unvested options for the three months ended March 31, 2014 is as follows:

 

    Number of options     Weighted-average
exercise price ($) per share
    Weighted-average
grant
date fair value ($) per option
 

Unvested options at December 31, 2013

    18,466        10.17        8.11   

Granted

    —          —          —     

Vested

    (9,283     10.45        8.33   

Cancelled

    (1,591     8.13        6.12   
 

 

 

     

Unvested options at March 31, 2014

    7,592        10.27        8.26   
 

 

 

     
Summary of Changes in Unvested Restricted Stock Units

A summary of changes in our restricted stock units for the three months ended March 31, 2014 is as follows:

 

     Number of RSUs     Weighted Average
Grant

Date
Fair Value ($)
 

Outstanding at December 31, 2013

     3,326,282        1.68   

Granted(1)

     594,874        1.34   

Vested and exercised

     (376,216     1.10   

Cancelled

     (400,000     1.84   
  

 

 

   

Outstanding at March 31, 2014

     3,144,940        1.66   
  

 

 

   

 

(1) 218,874 of these restricted stock units vest and convert into shares of our common stock after one year from the date of grant. 376,000 of these restricted stock units will vest and convert into shares of our common stock over a four year period from the date of grant; one-fourth of the award will vest on each grant date anniversary following the grant.